Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features

PURPOSE: Adjuvant! is a standardized validated decision aid that projects outcomes in operable breast cancer based on classical clinicopathologic features and therapy. Genomic classifiers offer the potential to more accurately identify individuals who benefit from chemotherapy than clinicopathologic...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Goldstein, Lori J., Gray, Robert, Badve, Sunil, Childs, Barrett H., Yoshizawa, Carl, Rowley, Steve, Shak, Steven, Baehner, Frederick L., Ravdin, Peter M., Davidson, Nancy E., Sledge, George W., Perez, Edith A., Shulman, Lawrence N., Martino, Silvana, Sparano, Joseph A.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Clinical Oncology 2008
Θέματα:
Breast Cancer
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2654377/
https://ncbi.nlm.nih.gov/pubmed/18678838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.14.4501
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια